First Time Loading...

Gujarat Themis Biosyn Ltd
BSE:506879

Watchlist Manager
Gujarat Themis Biosyn Ltd Logo
Gujarat Themis Biosyn Ltd
BSE:506879
Watchlist
Price: 408.7 INR 0.99% Market Closed
Updated: Apr 29, 2024
Section:
 

Wall Street
Price Targets

GUJTHEM Price Targets Summary
Gujarat Themis Biosyn Ltd

There are no price targets for GUJTHEM.
GUJTHEM Lowest Forecast
Wall Street Target
Not Available
GUJTHEM Average Forecast
Wall Street Target
Not Available
GUJTHEM Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Gujarat Themis Biosyn Ltd Competitors:
Price Targets
ROG
Roche Holding AG
28% Upside
4551
Torii Pharmaceutical Co Ltd
15% Upside
G
605507
Guobang Pharma Ltd
51% Upside
J
300497
Jiangxi Fushine Pharmaceutical Co Ltd
195% Upside
ROG
Roche Holding AG
28% Upside
4551
Torii Pharmaceutical Co Ltd
15% Upside
G
605507
Guobang Pharma Ltd
51% Upside
J
300497
Jiangxi Fushine Pharmaceutical Co Ltd
195% Upside
SOLARA
Solara Active Pharma Sciences Ltd
25% Downside
D
086450
Dongkook Pharmaceutical Co Ltd
54% Upside
Z
300702
Zhejiang Tianyu Pharmaceutical Co Ltd
46% Upside
CARA
Cara Therapeutics Inc
641% Upside

Revenue
Forecast

Revenue Estimate
Gujarat Themis Biosyn Ltd

For the last 8 years the compound annual growth rate for Gujarat Themis Biosyn Ltd's revenue is 21%. The projected CAGR for the next 6 years is -22%.

21%
Past Growth
-22%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Gujarat Themis Biosyn Ltd

Operating Income forecast
is not available for
Gujarat Themis Biosyn Ltd

Net Income
Forecast

Net Income Estimate
Gujarat Themis Biosyn Ltd

For the last 8 years the compound annual growth rate for Gujarat Themis Biosyn Ltd's net income is 37%. The projected CAGR for the next 6 years is -15%.

37%
Past Growth
-15%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
GUJTHEM intrinsic value, competitors valuation, and company profile.
DCF Valuation
GUJTHEM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GUJTHEM stock valuation using valuation multiples.
Wall Street Estimates
GUJTHEM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GUJTHEM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GUJTHEM's stock price target?
Not Available

GUJTHEM doesn't have any price targets made by Wall Street professionals.

What is Gujarat Themis Biosyn Ltd's Revenue forecast?
Projected CAGR
-22%

For the last 8 years the compound annual growth rate for Gujarat Themis Biosyn Ltd's revenue is 21%. The projected CAGR for the next 6 years is -22%.

What is Gujarat Themis Biosyn Ltd's Net Income forecast?
Projected CAGR
-15%

For the last 8 years the compound annual growth rate for Gujarat Themis Biosyn Ltd's net income is 37%. The projected CAGR for the next 6 years is -15%.

ALPHA SPREAD
Join more than 132,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.